Delivery Order SPE2DB20D1109-SPE2DB25FP27N
- Not listed
- AmerisourceBergen Drug Corp has been awarded a $1,592.96 delivery order by the Defense Logistics Agency (DLA) for 100 capsules of Dextroamphetamine-Amphetamine 30 mg, with a completion date of September 29, 2025. The award is a competitively procured, firm fixed-price contract with no set-aside designation. The pharmaceutical product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office headquarters. This...
- The Defense Logistics Agency awarded a $1,905.89 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Dextroamphetamine ER 10 mg capsules (100 count). The award was competitively procured with no set-aside designation and requires ultimate completion by July 15, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dextroamphetamine ER 10 mg capsules (100-count units) with a ceiling value of $2,586.96. The contract was competitively awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) with a ceiling value of $1,091.56. This is a firm fixed price delivery order with an ultimate completion date of September 18, 2025, and represents a non-competitive set-aside award. The contract will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $1,052.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 30 mg on September 18, 2025, with completion scheduled for September 19, 2025. This competitive award, which carried no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 25 mg, valued at $1,169.78. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed-price pricing and represents a direct fulfillment of pharmaceutical supply needs for federal military healthcare operations....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,119.60, is for the delivery of 4,568,135,213 units of Dextroamphetamine-Amphetamine 10 mg capsules. The contract is a firm fixed-price, non-set-aside award with a performance period through May 6, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $1,148.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg, with a completion date of September 12, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical supply will be delivered...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100 count) valued at $1,063.84 with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed price delivery order was issued on September 15, 2025, with no set-aside designation. The pharmaceutical supply will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award on July 14, 2025, for the supply of Dextroamphetamine SR Caps 15mg valued at $7,071.17. This non-set-aside, competitively awarded contract is funded by the Defense Logistics Agency's Medical Supply Chain and will be completed by July 15, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP27NDelivery Order
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) for Dextroamphetamine ER 10 mg capsules (90-count supply) valued at $1,149.48, with a completion date of June 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical supplier to the military healthcare enterprise. As a major pharmaceutical distributor, the company leverages its comprehensive DLA Prime Vendor contract to supply brand-name and generic medications across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. The DLA Troop Support Medical contract serves as a global pharmaceutical support vehicle, enabling the company to fulfill diverse military medical supply requirements through flexible ordering mechanisms such as this delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/23/25 |